IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools

Search About Journals, Conferences, and Book Series

Drug Target Insights

Impact, Factor and Metrics, Impact Score, Ranking, h-index, SJR, Rating, Publisher, ISSN, and More

Last Updated on June 27, 2025

Impact Score

2024-2025

1.90

h-Index

2024-2025

 17

Rank

2024-2025

 11994

SJR

2024-2025

 0.479

Note: The impact score or impact index shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics and Factor

Title Drug Target Insights
Abbreviation Drug Target Insights
Publication Type Journal
Subject Area, Categories, Scope Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Clinical Biochemistry (Q3); Medicine (miscellaneous) (Q3); Pharmacology (medical) (Q3)
h-index 17
Overall Rank/Ranking 11994
SCImago Journal Rank (SJR) 0.479
Impact Score 1.90
Publisher AboutScience Srl
Country Italy
ISSN 11773928
Best Quartile Q2
Coverage History 2008-2009, 2011-2024




About Drug Target Insights


Drug Target Insights is a journal covering the technologies/fields/categories related to Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Clinical Biochemistry (Q3); Medicine (miscellaneous) (Q3); Pharmacology (medical) (Q3). It is published by AboutScience Srl. The overall rank of Drug Target Insights is 11994. According to SCImago Journal Rank (SJR), this journal is ranked 0.479. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 17. The best quartile for this journal is Q2.

The ISSN of Drug Target Insights journal is 11773928. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Drug Target Insights is cited by a total of 80 articles during the last 3 years (Preceding 2024).


Drug Target Insights Impact IF 2024-2025


The Impact IF 2024 of Drug Target Insights is 1.90, which is computed in 2025 as per its definition. Drug Target Insights IF is decreased by a factor of 0.38 and approximate percentage change is -16.67% when compared to preceding year 2023, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Drug Target Insights Impact IF 2025 Prediction


Impact IF 2024 of Drug Target Insights is 1.90. If the same downward trend persists, Impact IF may fall in 2025 as well.


Impact IF Trend


Year wise Impact IF of Drug Target Insights. Based on Scopus data.


Year Impact IF
2025/2026 Coming Soon
2024 1.90
2023 2.28
2022 2.80
2021 2.60
2020 2.43
2019 2.60
2018 1.91
2017 2.23
2016 1.83
2015 3.23
2014 2.20

Drug Target Insights h-index


  Table Setting

Drug Target Insights has an h-index of 17. It means 17 articles of this journal have more than 17 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




Drug Target Insights ISSN


The ISSN of Drug Target Insights is 11773928. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

Drug Target Insights Rank and SCImago Journal Rank (SJR)


The overall rank of Drug Target Insights is 11994. According to SCImago Journal Rank (SJR), this journal is ranked 0.479. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.

SJR of Drug Target Insights by Year


Year SJR
2025/2026 Coming Soon
2024 0.479
2023 0.429
2022 0.690
2021 0.365
2020 0.297
2019 0.324
2018 0.310
2017 0.529
2016 0.790
2015 0.845
2014 0.435

Ranking of Drug Target Insights by Year


Year Ranking
2025/2026 Coming Soon
2024 11994
2023 12319
2022 7236
2021 12924
2020 14926
2019 13621
2018 13442
2017 8813
2016 5918
2015 5511
2014 10005

Drug Target Insights Publisher


Table Setting

Drug Target Insights is published by AboutScience Srl. It's publishing house is located in Italy. Coverage history of this journal is as following: 2008-2009, 2011-2024. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of Drug Target Insights is Drug Target Insights. This abbreviation ('Drug Target Insights') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in Drug Target Insights


If your research field is/are related to Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Clinical Biochemistry (Q3); Medicine (miscellaneous) (Q3); Pharmacology (medical) (Q3), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.



Frequently Asked Questions (FAQs)


What's the latest impact IF of the Drug Target Insights?

Drug Target Insights latest impact IF is 1.90. It's evaluated in the year 2024. The highest and the lowest impact IF or impact score of this journal are 3.23 (2015) and 1.83 (2016), respectively, in the last 11 years. Moreover, its average IS is 2.36 in the previous 11 years.


What's the SCImago Journal Rank (SJR) of the Drug Target Insights?

The Drug Target Insights has an SJR (SCImago Journal Rank) of 0.479, according to the latest data. It is computed in the year 2025. In the past 11 years, this journal has recorded a range of SJR, with the highest being 0.845 in 2015 and the lowest being 0.297 in 2020. Furthermore, the average SJR of the Drug Target Insights over the previous 11-year period stands at 2.36.


What's the latest h-index of the Drug Target Insights?

The latest h-index of the Drug Target Insights is 17.


Who's the publisher of the Drug Target Insights?

The Drug Target Insights is published by the AboutScience Srl, with its country of publication being the Italy.


What's the current ranking of the Drug Target Insights?

The Drug Target Insights is currently ranked 11994 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 11 years, this journal has experienced varying rankings, reaching its highest position of 5511 in 2015 and its lowest position of 14926 in 2020.


What's the abbreviation or short name for the Drug Target Insights?

The standard ISO4 abbreviation for the Drug Target Insights is Drug Target Insights.


Is the "Drug Target Insights" classified as a Journal, Conference and Proceedings, Trade Journal or Book Series?

Drug Target Insights is classified as a journal that the AboutScience Srl publishes.


What's the scope or major areas of the Drug Target Insights?

The Drug Target Insights encompasses the following areas:

  • Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
  • Clinical Biochemistry
  • Medicine (miscellaneous)
  • Pharmacology (medical)

For a more comprehensive understanding of its scope, check the official website of this journal.


What's the ISSN of the Drug Target Insights?

The Drug Target Insights is assigned the following International Standard Serial Numbers (ISSN): 11773928.


What's the best quartile of the Drug Target Insights?

The best quartile for the Drug Target Insights is Q2 (2024).


What's the coverage history of the Drug Target Insights?

The Drug Target Insights coverage history can be summarized as follows: 2008-2009, 2011-2024.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
Journal of Competition Law and Economics journal 11978 Oxford University Press 34 0.94
Journal of Applied Business Research journal 26260 Clute Institute 33 0.17
Child and Family Social Work journal 8793 Wiley-Blackwell Publishing Ltd 78 2.42
Syntax journal 2676 Wiley-Blackwell Publishing Ltd 35 1.10
Statistica journal 18529 University of Bologna 9 0.38
Population Review journal 19550 Sociological Demography Press 15 0.59
Journal of Sociology journal 6357 SAGE Publications Ltd 66 2.82
European Journal of Wildlife Research journal 10254 Springer Verlag 62 1.99
Expert Review of Clinical Pharmacology journal 4295 Taylor and Francis Ltd. 67 3.02
International Journal of Press/Politics journal 833 SAGE Publications Inc. 87 8.82

Check complete list




Year wise Impact Score (IS) of Drug Target Insights

Impact Score Table

Year Impact Score (IS)
2025/2026 Coming Soon
2024 1.90
2023 2.28
2022 2.80
2021 2.60
2020 2.43
2019 2.60
2018 1.91
2017 2.23
2016 1.83
2015 3.23
2014 2.20



Top Journals/Conferences in Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

Acta Pharmaceutica Sinica B
Chinese Academy of Medical Sciences | China

Theranostics
Ivyspring International Publisher | Australia

Current Protocols
John Wiley and Sons Inc | United States

Acta Materia Medica
Compuscript Ltd | Ireland

PLoS Neglected Tropical Diseases
Public Library of Science | United States

Life Sciences
Elsevier Inc. | United States

Clinical and Translational Science
John Wiley and Sons Inc | United Kingdom

Nanotheranostics
Ivyspring International Publishers | Australia

Frontiers in Toxicology
Frontiers Media SA | Switzerland

Antibiotics
Multidisciplinary Digital Publishing Institute (MDPI) | Switzerland

See All

Top Journals/Conferences in Clinical Biochemistry

Experimental and Molecular Medicine
Springer Nature | United Kingdom

Redox Biology
Elsevier B.V. | Netherlands

Biomarker Research
BioMed Central Ltd | United Kingdom

Journal of Biomedical Science
BioMed Central Ltd | United Kingdom

Molecular Aspects of Medicine
Elsevier Ltd | United Kingdom

Angiogenesis
Springer Science and Business Media B.V. | Netherlands

Cell Chemical Biology
Elsevier Ltd | United Kingdom

Apoptosis : an international journal on programmed cell death
Springer | United States

Journal of Clinical Endocrinology and Metabolism
Endocrine Society | United States

Antioxidants and Redox Signaling
Mary Ann Liebert Inc. | United States

See All

Top Journals/Conferences in Medicine (miscellaneous)

MMWR Recommendations and Reports
Centers for Disease Control and Prevention (CDC) | United States

Nature Reviews Drug Discovery
Nature Research | United Kingdom

New England Journal of Medicine
Massachussetts Medical Society | United States

Annals of Oncology
Elsevier Ltd | United Kingdom

Nature Medicine
Nature Research | United Kingdom

Nature Reviews Disease Primers
Nature Publishing Group | United Kingdom

Nature Reviews Immunology
Nature Research | United Kingdom

Nature Reviews Methods Primers
Springer Nature | United Kingdom

Annual Review of Pathology: Mechanisms of Disease
Annual Reviews Inc. | United States

Physiological Reviews
American Physiological Society | United States

See All

Top Journals/Conferences in Pharmacology (medical)

Drug Resistance Updates
Churchill Livingstone | United Kingdom

Pharmacology and Therapeutics
Elsevier Inc. | United States

Drugs
| Switzerland

Journal of Biomedical Science
BioMed Central Ltd | United Kingdom

npj Breast Cancer
Nature Publishing Group | United Kingdom

Alimentary Pharmacology and Therapeutics
John Wiley and Sons Inc | United Kingdom

American Journal of Transplantation
Elsevier B.V. | Netherlands

Acta Pharmacologica Sinica
Springer Nature | United Kingdom

BioDrugs
| Switzerland

npj Vaccines
Nature Publishing Group | United Kingdom

See All